Sacramento, Calif.-based Sutter Health and pharmaceutical giant AstraZeneca will launch an app this winter to help cancer patients manage and track chemotherapy drugs more easily.
The Latest
President Joe Biden awarded immunotherapy pioneer and longtime oncology physician Steven Rosenberg, MD, PhD, the National Medal of Technology and Innovation on Oct. 24.
About 60% of newly diagnosed cancer patients made at least one visit to the emergency department for symptoms, but only half of those resulted in hospitalization, a UT Southwestern's Simmons Cancer Center study found.
About 52% of oncologists reported experiencing burnout, according to a 2023 Medscape report.
It is possible to detect and treat dormant breast cancer cells, researchers at the University of Pennsylvania's Perelman School of Medicine and the Abramson Cancer Center found.
A recent study reduced the risk of disease progression or death by 55% in bladder cancer patients with a new combination of drugs, CNN reported Oct. 22.
A study from Boston-based Mass General Cancer Center found carcinogens can increase cancer cells' susceptibility to immune attack.
Rochester, Minn.-based Mayo Clinic has entered into a multiyear partnership with U.K.-based company Oxford Nanopore to explore genetic predispositions to cancer.
New York City-based Memorial Sloan Kettering Cancer Center is partnering with AstraZeneca and Sophia Genetics to bring its proprietary liquid biopsy and solid tumor cancer tests to a global market, according to an Oct. 18 news release.
Here are nine systems and organizations developing artificial intelligence models to find and treat cancer faster: